0001104659-15-012640.txt : 20150220
0001104659-15-012640.hdr.sgml : 20150220
20150220164638
ACCESSION NUMBER: 0001104659-15-012640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150207
FILED AS OF DATE: 20150220
DATE AS OF CHANGE: 20150220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BESHAR LUKE M
CENTRAL INDEX KEY: 0001192128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 15636295
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
a4.xml
4
X0306
4
2015-02-07
0
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001192128
BESHAR LUKE M
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
EVP & CFO
Common Stock
2015-02-07
4
J
0
8967
A
62780
D
Common Stock
2015-02-07
4
F
0
3148
45.85
D
59632
D
Common Stock
2015-02-12
4
M
0
3832
A
63464
D
Common Stock
2015-02-12
4
F
0
1427
45.85
D
62037
D
Common Stock
2015-02-13
4
M
0
10531
A
72568
D
Common Stock
2015-02-13
4
F
0
4789
45.88
D
67779
D
Common Stock
2015-02-17
4
M
0
3594
8.25
A
71373
D
Common Stock
2015-02-17
4
M
0
2969
8.21
A
74342
D
Common Stock
2015-02-17
4
M
0
859
38.27
A
75201
D
Restricted Stock Units
2015-02-12
4
A
0
10905
0
A
Common Stock
10905
10905
D
Restricted Stock Units
2015-02-12
4
M
0
3832
0
D
Common Stock
3832
7665
D
Restricted Stock Units
2015-02-13
4
M
0
10531
0
D
Common Stock
10531
10531
D
Employee Stock Option (right to buy)
8.25
2015-02-17
4
M
0
3594
8.25
D
2021-02-17
Common Stock
3594
3594
D
Employee Stock Option (right to buy)
8.21
2015-02-17
4
M
0
2969
8.21
D
2022-02-07
Common Stock
2969
14844
D
Employee Stock Option (right to buy)
38.27
2015-02-17
4
M
0
859
38.27
D
2024-02-12
Common Stock
859
30615
D
Shares acquired upon vesting of Restricted Stock Units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012.
The Reporting Person reported all Restricted Stock Units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
Restricted Stock Units will vest as follows: (i) one third will vest on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant, and (iii) one third on the third anniversary of date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.
On February 12, 2014, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant.
On February 13, 2013, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant.
On February 17, 2011, the Reporting Person received a grant of 57,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
On February 7, 2012, the Reporting Person received a grant of 47,500 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
On February 12, 2014, the Reporting Person received a grant of 31,474 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
/s/ Luke M. Beshar, by Jill Thompson as attorney-in-fact
2015-02-19